Browse > Article
http://dx.doi.org/10.5483/BMBRep.2021.54.11.129

Remodeling of host glycoproteins during bacterial infection  

Kim, Yeolhoe (Department of Systems Biology, BK21 Plus Project, College of Life Science and Biotechnology, Yonsei University)
Ko, Jeong Yeon (Department of Systems Biology, BK21 Plus Project, College of Life Science and Biotechnology, Yonsei University)
Yang, Won Ho (Department of Systems Biology, BK21 Plus Project, College of Life Science and Biotechnology, Yonsei University)
Publication Information
BMB Reports / v.54, no.11, 2021 , pp. 541-544 More about this Journal
Abstract
Protein glycosylation is a common post-translational modification found in all living organisms. This modification in bacterial pathogens plays a pivotal role in their infectious processes including pathogenicity, immune evasion, and host-pathogen interactions. Importantly, many key proteins of host immune systems are also glycosylated and bacterial pathogens can notably modulate glycosylation of these host proteins to facilitate pathogenesis through the induction of abnormal host protein activity and abundance. In recent years, interest in studying the regulation of host protein glycosylation caused by bacterial pathogens is increasing to fully understand bacterial pathogenesis. In this review, we focus on how bacterial pathogens regulate remodeling of host glycoproteins during infections to promote the pathogenesis.
Keywords
Bacterial infection; Pathogenesis; Protein glycosylation; Remodeling;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Grewal PK, Uchiyama S, Ditto D et al (2008) The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat Med 14, 648-655   DOI
2 Jank T, Bogdanovic X, Wirth C et al (2013) A bacterial toxin catalyzing tyrosine glycosylation of Rho and deamidation of Gq and Gi proteins. Nat Struct Mol Biol 20, 1273-1280   DOI
3 Goto Y, Obata T, Kunisawa J et al (2014) Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 345, 1254009   DOI
4 Aktories K, Schwan C and Jank T (2017) Clostridium difficile toxin biology. Annu Rev Microbiol 71, 281-307   DOI
5 Vaishnava S, Hooper LV (2007) Alkaline phosphatase: keeping the peace at the gut epithelial surface. Cell Host Microbe 2, 365-367   DOI
6 Belyi Y, Niggeweg R, Opitz B et al (2006) Legionella pneumophila glucosyltransferase inhibits host elongation factor 1A. Proc Natl Acad Sci U S A 103, 16953-16958   DOI
7 Tzivelekidis T, Jank T, Pohl C et al (2011) Aminoacyl-tRNA-charged eukaryotic elongation factor 1A is the bona fide substrate for Legionella pneumophila effector glucosyltransferases. PLoS One 6, e29525   DOI
8 Yang M, Li FG, Xie XS, Wang SQ and Fan JM (2014) CagA, a major virulence factor of Helicobacter pylori, promotes the production and underglycosylation of IgA1 in DAKIKI cells. Biochem Biophys Res Commun 444, 276-281   DOI
9 Barel M, Harduin-Lepers A, Portier L, Slomianny MC and Charbit A (2016) Host glycosylation pathways and the unfolded protein response contribute to the infection by Francisella. Cell Microbiol 18, 1763-1781   DOI
10 Yang WH, Heithoff DM, Aziz PV et al (2017) Recurrent infection progressively disables host protection against intestinal inflammation. Science 358, eaao5610   DOI
11 Pinho SS and Reis CA (2015) Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer 15, 540-555   DOI
12 Nothaft H and Szymanski CM (2010) Protein glycosylation in bacteria: sweeter than ever. Nat Rev Microbiol 8, 765-778   DOI
13 Jank T, Belyi Y and Aktories K (2015) Bacterial glycosyltransferase toxins. Cell Microbiol 17, 1752-1765   DOI
14 Ding J, Pan X, Du L et al (2019) Structural and functional insights into host death domains inactivation by the bacterial arginine GlcNAcyltransferase effector. Mol Cell 74, 922-935   DOI
15 Gao X, Wang X, Pham TH et al (2013) NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation. Cell Host Microbe 13, 87-99   DOI
16 Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A and Minton NP (2010) The role of toxin A and toxin B in Clostridium difficile infection. Nature 467, 711-713   DOI
17 Bhat AH, Maity S, Giri K and Ambatipudi K (2019) Protein glycosylation: sweet or bitter for bacterial pathogens? Crit Rev Microbiol 45, 82-102   DOI
18 Moremen KW, Tiemeyer M and Nairn AV (2012) Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol 13, 448-462   DOI
19 Szymanski CM and Wren BW (2005) Protein glycosylation in bacterial mucosal pathogens. Nat Rev Microbiol 3, 225-237   DOI
20 Pickard JM, Maurice CF, Kinnebrew MA et al (2014) Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature 514, 638-641   DOI
21 Poole J, Day CJ, von Itzstein M, Paton JC and Jennings MP (2018) Glycointeractions in bacterial pathogenesis. Nat Rev Microbiol 16, 440-452   DOI
22 Lu Q, Li S and Shao F (2015) Sweet talk: protein glycosylation in bacterial interaction with the host. Trends Microbiol 23, 630-641   DOI
23 Sudhakara P, Sellamuthu I and Aruni AW (2019) Bacterial sialoglycosidases in virulence and pathogenesis. Pathogens 8, 39   DOI
24 Chen GY, Chen X, King S et al (2011) Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction. Nat Biotechnol 29, 428-435   DOI
25 Paulson JC and Kawasaki N (2011) Sialidase inhibitors DAMPen sepsis. Nat Biotechnol 29, 406-407   DOI
26 Kurniyati K, Zhang W, Zhang K and Li C (2013) A surface-exposed neuraminidase affects complement resistance and virulence of the oral spirochaete Treponema denticola. Mol Microbiol 89, 842-856   DOI
27 Garbe J, Sjogren J, Cosgrave EF et al (2014) EndoE from Enterococcus faecalis hydrolyzes the glycans of the biofilm inhibiting protein lactoferrin and mediates growth. PLoS One 9, e91035   DOI
28 Naegeli A, Bratanis E, Karlsson C et al (2019) Streptococcus pyogenes evades adaptive immunity through specific IgG glycan hydrolysis. J Exp Med 216, 1615-1629   DOI
29 Collin M and Fischetti VA (2004) A novel secreted endoglycosidase from Enterococcus faecalis with activity on human immunoglobulin G and ribonuclease B. J Biol Chem 279, 22558-22570   DOI
30 Sjogren J and Collin M (2014) Bacterial glycosidases in pathogenesis and glycoengineering. Future Microbiol 9, 1039-1051   DOI
31 Pham TA, Clare S, Goulding D et al (2014) Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen. Cell Host Microbe 16, 504-516
32 Zhu TT, Wang L, Wang HL, He Y, Ma X and Fan JM (2016) Helicobacter pylori participates in the pathogenesis of IgA nephropathy. Ren Fail 38, 1398-1404   DOI
33 Yang WH, Heithoff DM, Aziz PV et al (2018) Accelerated aging and clearance of host anti-inflammatory enzymes by discrete pathogens fuels sepsis. Cell Host Microbe 24, 500-513   DOI
34 Goto Y, Uematsu S and Kiyono H (2016) Epithelial glycosylation in gut homeostasis and inflammation. Nat Immunol 17, 1244-1251   DOI
35 Scott NE, Giogha C, Pollock GL et al (2017) The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD). J Biol Chem 292, 17337-17350   DOI
36 Collin M and Olsen A (2001) EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J 20, 3046-3055   DOI
37 Renzi F, Manfredi P, Mally M, Moes S, Jeno P and Cornelis G (2011) The N-glycan glycoprotein deglycosylation complex (Gpd) from Capnocytophaga canimorsus deglycosylates human IgG. PLoS Pathog 7, 17
38 Rudd P, Elliott T, Cresswell P, Wilson I and Dwek R (2001) Glycosylation and the immune system. Science 291, 2370-2376   DOI